Hemp product manufacturer Haleigh’s Hope says it is raising a quality flag in the hemp/CBD category by getting a GMP certification on its production facility from a third party verifier.
Belgium’s Federal Agency for Food Chain Safety (AFSCA) warns consumers to avoid the same curcumin-based supplement known to Italian authorities after the country also reports cases of acute cholestatic hepatitis.
An interim final rule on CBD is a viable way for FDA to break the logjam on this increasingly popular ingredient, according to the head of one industry trade organization.
China’s State Administration for Market Regulation (SAMR) is encouraging health food firms to contribute to the expansion of the Health Food Raw Materials Directory by presenting evidence to support the functional efficacy of ingredients to the unit.
The American Herbal Products Association is planning a hemp/CBD event in August in Colorado for dietary supplement companies interested in the ingredient.
Colorado has convened a commission to formulate an agricultural plan for the cultivation of industrial hemp in the state. A longtime supplement and natural foods industry consultant is among the participants.
Oregon Sen. Ron Wyden has put further pressure on FDA with a letter requesting a formal announcement of enforcement discretion on the CBD question while a more permanent regulatory solution is hashed out.
By the end of 2019, 98% of food and beverage products will have adopted a standardized version of date labeling – ‘Best If Used By' – with complete adoption anticipated by January 2020, predict the Grocery Manufacturers Association (GMA) and the...
There are several ingredient lists on FDA’s website that imply some sort of warning to the public. But what's the criteria that decides into which list an ingredient will fall?
A new BAPP bulletin has been published that details adulteration in aloe vera ingredients, which are among the most popular in the entire botanicals industry.
The news this week of the approval of a slate of new qualified health claims for omega-3s shows that even an old dog like fish oil can still learn new tricks.
An amendment advocated by the Natural Products Association that would earmark funds for CBD regulation was including in the final version of the 2019 appropriations bill passed by the US House of Representatives.
The US Food and Drug Administration has approved a list of qualified health claims for omega-3 fatty acids and their effect on blood pressure, culminating a five year plus effort on the part of industry.
An amendment to the National Defense Authorization Act (NDAA) introduced to Congress would require the creation of a reporting system for adverse events that may be associated with dietary supplements use in the military. Trade group CRN is pushing back,...
